The document proposes establishing a joint venture company between Bioland LTD and a Vietnamese partner, Nam-Khoa Biotek LTD, to produce rapid diagnostic tests in Vietnam. There is increasing demand for such tests in countries like Vietnam to detect diseases like malaria, hepatitis, HIV, and others. The joint venture would manufacture tests for diseases locally to sell in Vietnam and abroad, leveraging Bioland's expertise in research and development and manufacturing and Nam-Khoa's facilities, sales network, and regulatory knowledge in Vietnam. The proposal outlines contributions, governance, production plans, timelines, and profit distribution between the partners.